Tvardi Therapeutics (TVRD)

Tvardi Therapeutics on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

376K

Short interest

settlement 2026-10-15

2.2

Days to cover

+1.2 days vs prior

24.8%

Short share of volume

2026-11-02

3,741

Fails to deliver

settlement 2026-10-01

Thu 12 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 36 settlements in the table, 36 in the chart. JSON

As of 15 October 2026, short interest in TVRD is 375,939 shares, up 120,413 shares over the last month. Over the last 36 readings it ranged from 9,554 shares (30 April 2025) to 1,175,876 shares (15 October 2025). At the reported average volume of 168K shares a day that is 2.2 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/tvrd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	375,939	+67.5%	168,469	2.23
2026-09-30	224,403	-12.2%	296,698	1.00
2026-09-15	255,526	-3.6%	111,784	2.29
2026-08-31	264,990	+52.9%	141,542	1.87
2026-08-14	173,306	-34.0%	271,752	1.00
2026-07-31	262,477	-51.7%	793,416	1.00
2026-07-15	542,999	+7.0%	12,496,857	1.00
2026-06-30	507,431	+27.5%	701,359	1.00
2026-06-15	397,991	-8.7%	57,855	6.88
2026-05-29	436,072	-11.0%	54,550	7.99
2026-05-15	490,170	-3.7%	44,199	11.09
2026-04-30	508,941	-8.2%	34,273	14.85
2026-04-15	554,342	-15.2%	68,655	8.07
2026-03-31	653,882	-2.2%	48,902	13.37
2026-03-13	668,566	+5.0%	41,646	16.05
2026-02-27	636,750	-13.8%	41,838	15.22
2026-02-13	738,313	+11.2%	62,102	11.89
2026-01-30	663,746	+21.2%	50,296	13.20
2026-01-15	547,713	-13.4%	123,939	4.42
2025-12-31	632,646	-29.8%	162,331	3.90
2025-12-15	901,651	-2.5%	109,172	8.26
2025-11-28	925,143	+4.5%	105,076	8.80
2025-11-14	885,749	-13.6%	189,048	4.69
2025-10-31	1,024,770	-12.8%	421,309	2.43
2025-10-15	1,175,876	+38.2%	850,712	1.38
2025-09-30	850,911	+26.0%	93,813	9.07
2025-09-15	675,167	-0.8%	22,205	30.41
2025-08-29	680,399	+3.0%	22,536	30.19
2025-08-15	660,592	+11.2%	22,442	29.44
2025-07-31	594,235	+14.4%	34,129	17.41
2025-07-15	519,622	+1.1%	38,522	13.49
2025-06-30	514,107	+212.4%	148,889	3.45
2025-06-13	164,552	+1.0%	51,912	3.17
2025-05-30	162,894	+149.7%	57,665	2.82
2025-05-15	65,229	+582.7%	38,602	1.69
2025-04-30	9,554	-86.5%	35,906	1.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of TVRD volume is 24.8%, down 27.1 points over the last five sessions. Over the last 30 readings it ranged from 24.8% (2 November 2026) to 87.1% (2 October 2026). The latest reading sits at the bottom of that range. The latest reading is 28.9 points below the 30-session average of 53.6%, on 44K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	11K	44K	24.8%	33
2026-10-30	66K	100K	66.1%	50
2026-10-29	60K	76K	79.6%	0
2026-10-28	18K	35K	52.1%	0
2026-10-27	14K	53K	26.6%	849
2026-10-26	55K	106K	51.9%	11
2026-10-23	19K	52K	37.0%	1,524
2026-10-22	29K	37K	77.0%	0
2026-10-21	26K	69K	36.9%	411
2026-10-20	35K	71K	49.7%	2,000
2026-10-19	66K	119K	55.7%	100
2026-10-16	31K	52K	59.7%	0
2026-10-15	18K	55K	32.2%	0
2026-10-14	30K	51K	59.4%	0
2026-10-13	13K	44K	28.6%	0
2026-10-12	115K	166K	69.3%	0
2026-10-09	47K	78K	60.4%	0
2026-10-08	29K	52K	55.9%	0
2026-10-07	61K	77K	78.6%	0
2026-10-06	44K	82K	53.3%	0
2026-10-05	62K	106K	58.2%	0
2026-10-02	194K	222K	87.1%	0
2026-10-01	84K	175K	48.1%	1,247
2026-09-30	62K	95K	65.1%	0
2026-09-29	81K	171K	47.4%	0
2026-09-28	82K	155K	52.8%	214
2026-09-25	232K	451K	51.4%	37,688
2026-09-24	172K	360K	47.9%	30,317
2026-09-23	120K	261K	45.9%	15,067
2026-09-22	22K	45K	50.0%	0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 1 October 2026, the fails-to-deliver balance in TVRD is 3,741 shares, up 954 shares over the last settlement date. Over the last 30 readings it ranged from 8 shares (6 July 2026) to 677,680 shares (10 July 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-01	3,741	$1.25	$5K
2026-09-24	2,787	$1.32	$4K
2026-09-16	1,117	$1.76	$2K
2026-09-15	1,352	$1.83	$2K
2026-09-11	442	$1.84	$813
2026-08-31	22,503	$1.82	$41K
2026-08-03	19,432	$2.10	$41K
2026-07-31	28,072	$2.10	$59K
2026-07-30	10	$2.14	$21
2026-07-28	191,950	$2.54	$488K
2026-07-27	15,178	$2.51	$38K
2026-07-21	9,062	$2.93	$27K
2026-07-15	11,438	$3.10	$35K
2026-07-10	677,680	$3.80	$2.6M
2026-07-09	148,183	$5.00	$741K
2026-07-08	537,307	$3.10	$1.7M
2026-07-06	8	$2.02	$16
2026-07-02	420	$1.95	$819
2026-07-01	710	$1.90	$1K
2026-06-30	66,496	$1.91	$127K
2026-06-26	1,379	$2.36	$3K
2026-06-25	568	$2.35	$1K
2026-06-17	1,976	$2.63	$5K
2026-06-15	4,256	$2.64	$11K
2026-06-10	15	$2.78	$42
2026-06-03	100	$3.17	$317
2026-06-02	100	$3.22	$322
2026-05-27	447	$3.44	$2K
2026-05-22	404	$3.59	$1K
2026-05-19	10,001	$4.00	$40K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for TVRD in the last 90 days. The most recent filings are listed below. Latest filing: Tweardy Samuel David (10% owner) on 2025-07-07.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2025-07-07	Tweardy Samuel David	10% owner	Other transaction	316K	$0.00	$0	0
2025-07-07	Tweardy Samuel David	10% owner	Other transaction	316K	$0.00	$0	0
2025-04-15	Wirk Shaheen	Director	Other transaction	176K	price not stated in the filing	not stated	176K
2025-04-15	Wirk Shaheen	Director	Other transaction	263K	price not stated in the filing	not stated	263K
2025-04-15	Wirk Shaheen	Director	Grant	4K	price not stated in the filing	not stated	4K
2025-04-15	HALL WALLACE L JR	Director	Other transaction	45K	price not stated in the filing	not stated	45K
2025-04-15	HALL WALLACE L JR	Director	Other transaction	202K	price not stated in the filing	not stated	202K
2025-04-15	Wirk Shaheen	Director	Grant	176K	price not stated in the filing	not stated	176K
2025-04-15	Wirk Shaheen	Director	Grant	263K	price not stated in the filing	not stated	263K
2025-04-15	HALL WALLACE L JR	Director	Grant	202K	price not stated in the filing	not stated	202K
2025-04-15	HALL WALLACE L JR	Director	Grant	45K	price not stated in the filing	not stated	45K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

No holder on file reports 5% or more of TVRD in its latest filing.

Filed	Form	Holder	Shares	Of class	Event
2026-02-17	13G/Ano. 2	Ronald A. DePinhoindividual	426K	4.5%	2025-12-31

13F holders

Tracked managers holding TVRD at their latest 13F. JSON

2 of the 30 tracked managers held TVRD at their latest 13F, $225K in total at quarter-end prices. Renaissance Technologies is the largest at $174K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 2 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Renaissance Technologies	2026-06-30	91K	$174K	0.00%	-691
AQR Capital Management	2026-06-30	27K	$51K	0.00%	-15K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Tvardi Therapeutics in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Tvardi Therapeutics (TVRD), SEC CIK 1346830, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-01.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-02-17.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2025-07-07.JSON and CSV
Company record: EDGAR filing index for CIK 1346830Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of TVRD is sold short?

375,939 shares were held short at the 2026-10-15 settlement, 2.2 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is TVRD's daily short volume?

On 2026-11-02, 11,011 of the 44,468 TVRD shares reported to FINRA were sold short, 24.8% of the day's reported volume. Short volume is a flow for one day, not a position.

Does TVRD have fails to deliver?

The SEC's latest file shows 3,741 TVRD shares failed to deliver at settlement 2026-10-01. Fails are reported per settlement date and published twice a month with a lag.

Are TVRD insiders buying or selling?

No open-market insider trades were reported for TVRD in the last 90 days. The most recent filings are listed below. Latest filing: Tweardy Samuel David (10% owner) on 2025-07-07.

Who owns 5% or more of TVRD?

No holder on file reports 5% or more of TVRD in its latest filing.

Which tracked 13F managers own TVRD?

2 of the 30 tracked 13F managers held TVRD shares at their latest filing, $225K in all. The largest: Renaissance Technologies (91K shares, $174K), Cliff Asness's AQR Capital Management (27K shares, $51K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

Tvardi Therapeutics (TVRD)

Short interest

Daily short volume

Fails to deliver

Insider trades

Large holders (13D and 13G)

13F holders

Tvardi Therapeutics in the regulatory record

Source and updates

How to read it

Other company pages

Datasets

Frequently Asked Questions